Anastrozole (Arimidex), letrozole (Femara), and exemestane (Aromasin) are members of the third generation of aromatase inhibitors that has now replaced aminoglutethimide (Cytadren), the progestins, and tamoxifen
Anne Hamilton, MBBS
Advertisement
Articles by Anne Hamilton, MBBS
Advertisement
Latest Updated Articles
- Nonsteroidal and Steroidal Aromatase Inhibitors in Breast Cancer
Published: August 1st 2001 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
Frontline Tislelizumab Combo Improves Long-Term Survival in ES-SCLC
3
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
4
Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment
5
